We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLNT icon
2701
Planet Fitness
PLNT
$4.09B
-3,218
Closed -$249K
PLTR icon
2702
Palantir
PLTR
$432B
-218,218
Closed -$5.08M
PM icon
2703
Philip Morris
PM
$293B
-95,086
Closed -$8.44M
PNTG icon
2704
Pennant Group
PNTG
$1.36B
-8,881
Closed -$407K
POOL icon
2705
Pool Corp
POOL
$6.83B
-3,712
Closed -$1.28M
PPG icon
2706
PPG Industries
PPG
$25.3B
-12,204
Closed -$1.83M
PRAA icon
2707
PRA Group
PRAA
$737M
-6,435
Closed -$239K
PRCH icon
2708
Porch Group
PRCH
$1.94B
-186,569
Closed -$3.3M
PRDO icon
2709
Perdoceo Education
PRDO
$2.07B
-53,708
Closed -$642K
PRGO icon
2710
Perrigo
PRGO
$1.98B
-20,448
Closed -$828K
PRQR icon
2711
ProQR Therapeutics
PRQR
$330M
-10,700
Closed -$71K
PSA icon
2712
Public Storage
PSA
$60.2B
-9,492
Closed -$2.34M
PSTL
2713
Postal Realty Trust
PSTL
$693M
-49,145
Closed -$844K
PVH icon
2714
PVH
PVH
$3.62B
-13,800
Closed -$1.46M
QDEL icon
2715
QuidelOrtho
QDEL
$1.01B
-9,181
Closed -$1.18M
R icon
2716
Ryder
R
$9.58B
-2,766
Closed -$209K
RA
2717
Brookfield Real Assets Income Fund
RA
$693M
-10,511
Closed -$218K
RAMP icon
2718
LiveRamp
RAMP
$2.28B
-23,549
Closed -$1.22M
RCEL icon
2719
Avita Medical
RCEL
$311M
-98,305
Closed -$1.95M
RDN icon
2720
Radian Group
RDN
$4.84B
-46,538
Closed -$1.08M
RES icon
2721
RPC Inc
RES
$1.41B
-82,824
Closed -$447K
REYN icon
2722
Reynolds Consumer Products
REYN
$5.37B
-34,362
Closed -$1.02M
RFL icon
2723
Rafael Holdings
RFL
$112M
-7,428
Closed -$292K
RGEN icon
2724
Repligen
RGEN
$10.2B
-10,880
Closed -$2.12M
RGP icon
2725
Resources Connection
RGP
$149M
-46,749
Closed -$633K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.